Agonism and antagonism at the insulin receptor.
Insulin can trigger metabolic as well as mitogenic effects, the latter being pharmaceutically undesirable. An understanding of the structure/function relationships between insulin receptor (IR) binding and mitogenic/metabolic signalling would greatly facilitate the preclinical development of new ins...
Main Authors: | Louise Knudsen, Bo Falck Hansen, Pia Jensen, Thomas Åskov Pedersen, Kirsten Vestergaard, Lauge Schäffer, Blagoy Blagoev, Martin B Oleksiewicz, Vladislav V Kiselyov, Pierre De Meyts |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3531387?pdf=render |
Similar Items
-
Molecular basis of agonism and antagonism in the oestrogen receptor.
by: Brzozowski, A, et al.
Published: (1997) -
Structural aspects of agonism and antagonism in the oestrogen receptor.
by: Pike, A, et al.
Published: (2000) -
Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
by: Jonathan E. Campbell
Published: (2021-04-01) -
Structural insights into the mechanisms of agonism and antagonism in oestrogen receptor isoforms.
by: Hubbard, R, et al.
Published: (2000) -
Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
by: Katrine D. Galsgaard, et al.
Published: (2022-12-01)